Urology

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Urinary Bladder Neoplasms 57%
3. Prostate 55%
4. Brachytherapy 45%
5. Neoplasms 40%
6. Robotics 38%
7. Nephrectomy 33%
8. Cystectomy 31%
9. Carcinoma 28%
10. Prostatectomy 28%
11. Prostate-Specific Antigen 27%
12. Therapeutics 25%
13. Survival 24%
14. Drug Therapy 22%
15. Castration 18%
16. Urinary Bladder 17%
17. Kidney 16%
18. Renal Cell Carcinoma 16%
19. Biopsy 15%
20. Prostatic Hyperplasia 15%
21. Urology 14%
22. Cisplatin 14%
23. Androgens 13%
24. Recurrence 13%
25. Radiotherapy 11%
26. Multiparametric Magnetic Resonance Imaging 11%
27. Muscles 11%
28. Seeds 11%
29. Human Herpesvirus 4 9%
30. Nomograms 9%
31. Neoplasm Grading 9%
32. Systematic Reviews 9%
33. Erectile Dysfunction 9%
34. Databases 8%
35. Neoplasm Metastasis 8%
36. Confidence Intervals 8%
37. Urologists 8%
38. Clinical Trials 8%
39. Kidney Neoplasms 8%
40. Immunotherapy 8%
41. Nephroureterectomy 8%
42. Surgeons 8%
43. Platinum 8%
44. Penile Prosthesis 8%
45. Meta-Analysis 7%
46. Seminal Vesicles 7%
47. Radiation 7%
48. Lymph Node Excision 7%
49. Morbidity 6%
50. Quality of Life 6%
51. Urinary Incontinence 6%
52. Urinary Diversion 6%
53. Mortality 6%
54. Neoadjuvant Therapy 6%
55. Pandemics 6%
56. Lymph Nodes 6%
57. Safety 5%
58. Transurethral Resection of Prostate 5%
59. Population 5%
60. Biomarkers 5%
61. Hormones 5%
62. Margins of Excision 5%
63. Docetaxel 5%
64. Androgen Receptors 5%
65. Progression-Free Survival 5%
66. Incidence 5%
67. Length of Stay 5%
68. Nivolumab 5%
69. Cystoscopy 5%
70. Lower Urinary Tract Symptoms 5%
71. Genes 5%
72. Urine 5%